The Food and Drug Administration approved a new weight-loss drug on Friday, marking the first time the agency has approved such a drug since 2014.

The agency greenlighted the Wegovy injection, used for chronic weight management in adults who are obese or overweight. Recommended users of the drug must have at least one weight-related condition such as high blood pressure or Type 2 diabetes, and must use the drug along with engaging in more exercise and a reduced calorie diet.